Safety of Tepotinib in Patients With MET Exon 14 Skipping NSCLC and Recommendations for Management. Veillon R, Sakai H, Le X, Felip E, et al. Clin Lung Cancer 2022;23:320-332.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Veillon R, Sakai H, Le X, Felip E, et al. Safety of Tepotinib in Patients With MET Exon 14 Skipping NSCLC and Recommendations for Management. Clin Lung Cancer 2022;23:320-332.
PMID: 35466070